$AZN

2 theses

bullish 100%neutral 0%bearish 0%

Avg return (6m)

—

Win rate (6m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Nov 2, 4:15 PM ET

$AZNr/ValueInvestingIndustry/Sectorbullish

u/Sylentwolf8 · 87d ago3 prior · awaiting results

The Chinese State 5-Year Plan - Who will profit?

Western pharma giants like AstraZeneca are positioned to acquire global rights to promising Chinese state-subsidized biotech discoveries at favorable valuations, leveraging their established global distribution networks to commercialize these assets at high margins while China handles early-stage R&D subsidies.

At post $161.42Now $186.58+15.6% since postedas of Nov 2, 4:15 PM ET

1d—

3d+0.3%

1w-3.1%

1m+0.8%

3m—

6m—

1y—

original post →

$AZNr/wallstreetbetsDiscussionbullish

u/fatuousfatwa · 98d agono track record yet

Long AZN $155C exp Aug 31

$8000 call bet on AZN

AZN beat on earnings with a $0.13 EPS beat and reaffirmed strong 2030 guidance of $80B (33% higher than 2026) plus positive cancer drug results with $5B annual potential. Author expects upgrades and sector rotation into underperforming pharma, betting via August $155 calls.

At post $169.64Now $186.58+10.0% since postedas of Nov 2, 4:15 PM ET

1d+1.7%

3d+1.0%

1w-6.9%

1m-2.0%

3m+1.1%

6m—

1y—

original post →

End of results.